Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors.
Stem cell treatment for Multiple sclerosis is effective because stromal stem are able to cross the blood-brain barrier and copy neural stem cell activity. This leads to replacement of damaged cells and restoration of brain function
What is the difference between Stem Cells and Normal Cells – Stem cells can divide; normal cells may or may not have the ability to divide. Stem cells do not
What is the difference between IPS Cells and Embryonic Stem Cells? IPS cells are the cells generated in vitro by reprogramming the adult somatic cells to
Induced pluripotent stem cells, commonly abbreviated as iPS cells or iPSCs, are a type of pluripotent stem cell artificially derived from a non-pluripotent cell, typically an adult somatic cell, by inducing a “forced” expression of certain genes and transcription factors.
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Embryonic stem cell research is a hot topic that seems to pit anti-abortion conservatives against pro-abortion liberals. The conservatives claim that there are better alternatives to embryonic stem cells, while the liberals claim that conservatives are blocking research that will provide cures to many tragic diseases.
Human Intestinal Tissue with Adult Stem Cell Properties Derived from Pluripotent Stem Cells
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Deﬁned Factors Kazutoshi Takahashi,1 Koji Tanabe,1 Mari Ohnuki,1 Megumi Narita,1,2 Tomoko Ichisaka,1,2 Kiichiro Tomoda,3
Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The iPSC technology was pioneered by Shinya Yamanaka’s lab in Kyoto, Japan, who showed in 2006 that the introduction of four specific genes encoding transcription factors could convert adult